Member Contact: Paul MacLeman
Position: Managing Director
Industry: Biotech & Pharmaceuticals
IDT is an Australian pharmaceutical contract manufacturing company with 25 years experience in the development and production of highly potent (HPAPI) pharmaceutical products for local and international clients.
IDT provides support services for new drug development and scale-up projects through its newly upgraded laboratory facilities. These facilities are divided into two areas: Research and Development (R&D) and Analytical.
IDT also offers a comprehensive range of specialist formulation development manufacturing, packaging and dispensing services for new products and clinical trial supplies. In addition, we manufacture, under GMP, active and placebo clinical trial supplies in a variety of dosage forms, including tablets, capsules, suspensions, liquids, and ointments.
CMAX, a division of IDT Australia, offers a comprehensive range of services for the design, implementation and management of clinical studies, specialising in Phase I and participating in Phase II to IV as an investigative site. These studies are conducted in a world class 48 bed facility for both local and international regulatory submissions. All studies are conducted in compliance with the principles of ICH GCP and local regulatory requirements and are internally audited